S&P DJI Announces March 2022 Quarterly Rebalance
Filed with ASX · · 10 pages · English
EMvision Medical Devices Ltd. on 6ix
Story so far
Earlier from EMvision Medical Devices
- Application for quotation of securities - EMV
- EMV Technology to be Presented at Prestigious Conference
- EMVision Receives $3.4m Non-Dilutive Funding this Quarter
- Notification regarding unquoted securities - EMV
- Clinical Trial Data Drives Confidence for Expanded Studies
Later from EMvision Medical Devices
- New Appointments to Clinical Advisory Board
- EMVision Secures Strategic Agreement With Keysight
- Pause in Trading
- EMVision Awarded $5m Non-Dilutive Funding via MMI Grant
- EMVision Achieves First Responder Milestone
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices